Market Correction Resilience: Why Some High-Valuation Stocks Defy Downturns
Why Some Expensive Stocks Hold Up During Market Corrections

Market Correction Resilience: Why Some High-Valuation Stocks Defy Downturns

Market corrections typically expose valuation excesses, with stocks priced for perfection often correcting sharply as earnings visibility weakens and risk appetite declines. However, certain companies consistently hold their ground despite trading at elevated price-to-earnings multiples, creating confusion among investors who expect high valuations to make these stocks particularly vulnerable during downturns.

Markets don't evaluate valuation in isolation during corrections. Instead, they differentiate between stocks where confidence breaks quickly and those where investor conviction remains intact. This selective resilience explains why some high P/E stocks maintain stability when broader markets turn volatile.

Laurus Labs: The Long-Term CDMO Payoff Strategy

Laurus Labs Ltd, a research-driven pharmaceutical and biotechnology company, operates through a diverse portfolio including Generics (API and FDF) and Contract Development and Manufacturing Organization services. The company holds leadership positions across therapeutic areas including antiretrovirals, oncology, and cardiovascular treatments.

In H1 FY26, Laurus demonstrated remarkable financial performance:

  • Total income from operations increased 33% year-on-year to ₹3,223 crore
  • Ebitda reached ₹818 crore with margins expanding to 25.4%
  • Net profit grew nearly tenfold to ₹356 crore from a low base of ₹33 crore in H1 FY25

Despite trading at a rich multiple of 81 times earnings—significantly higher than competitors like Divi's Laboratories (65) and Sai Life Sciences (61)—the company's share price has surged 76% from last year to ₹1,030.

Laurus is pursuing an aggressive expansion strategy focused on capacity additions and new technology approaches. The company proposes investing approximately $600 million over eight years to build a world-class pharmaceutical manufacturing complex, with an estimated capex of about ₹1,000 crore in FY26 alone.

The CDMO division is transitioning from early-phase to commercial deliveries, requiring significant upfront capital expenditure and validation time of 18-24 months. Management remains optimistic about improving Ebitda margins over the next 12-24 months as operating leverage kicks in and the product mix shifts toward high-margin CDMO and complex commercial assets.

Additional growth initiatives include:

  1. Expansion into animal health with facilities undergoing multiple product validations
  2. Development of Crop Science segment currently in qualification phase
  3. Construction of a new Gene/ADC facility in Hyderabad expected to be completed by end-2026

Jain Resource Recycling: Riding the Formalization Tailwind

Jain Resource Recycling Ltd operates as a vertically integrated non-ferrous metal recycling business, processing scrap materials procured domestically and internationally. The company boasts significant market share in lead (8.6%), copper (3.4%), and aluminium (0.5%) recycling.

The company's business aligns perfectly with rising demand for recycling and formalization of the sector. Mandated minimum recycled content requirements (5% each for copper and aluminium from 2028) are expected to shift market share from unorganized to organized players like Jain.

Financial performance in H1 FY26 was impressive:

  • Revenue grew 27% year-over-year to ₹3,663 crore
  • Ebitda increased 37% to ₹250 crore with margins expanding 52 basis points to 6.8%
  • Net profit surged 38% to ₹155 crore

Since listing in October 2025, Jain has delivered a 19% return at the current price of ₹381, despite commanding a sector-high valuation premium of 52 times earnings.

The company maintains strong customer stickiness, with repeat customers accounting for nearly 88% of revenue in H1 FY26. Jain follows a policy of adding 20% additional capacity annually to stay ahead of demand, with lead capacity utilization currently near 100%.

Future growth initiatives include:

  1. Setting up a manufacturing facility for copper cathodes, wire rods, and busbars expected to begin operations in Q1 FY27
  2. Joint venture with US-based C&Y Group to establish a ₹60 crore copper scrap recycling plant
  3. Exploration of new recycling domains including tyre recycling, solar panel recycling, and e-waste processing

Syrma SGS Technology: Margin-First Business Reset

Syrma SGS Technology Ltd has established itself as a significant player in India's Electronic System Design and Manufacturing landscape, offering integrated box-build solutions and customized end-of-line testing. The company has carved niches in Radio Frequency Identification and supplies critical communication solutions to sectors with high entry barriers including public safety, oil and gas, medical devices, and paramilitary forces.

Despite sector volatility, Syrma's stock has demonstrated resilience, trading at a price-to-earnings multiple of 56 times at ₹668 per share and delivering a 43% return over the last year.

The company's strategic rebalancing explains this performance. While H1 FY26 revenue grew modestly by 4.4% year-on-year to ₹2,093 crore, profitability metrics showed dramatic improvement:

  • Ebitda rose sharply by 60% to ₹227 crore
  • Margins expanded 370 basis points to 10.7%
  • Net profit nearly doubled to ₹116 crore

Syrma is deliberately moving away from lower-margin consumer electronics toward higher-margin industrial and automotive segments. This transition has slowed near-term revenue momentum but yielded significant margin gains. The consumer vertical's revenue declined 23% to ₹683 crore, reducing its share from 40% to 32% of total revenue.

Conversely, industrial revenues rose 20% to ₹552 crore, automotive grew 24%, healthcare increased 21%, and exports surged 35%. The company maintains strong visibility with an order book of approximately ₹5,800 crore, representing about 1.5 years of revenue visibility.

Syrma is diversifying into new growth engines aligned with long-term domestic manufacturing priorities:

  1. Defence business targeted to grow from ₹200 crore to ₹300-350 crore in the next 2-3 years
  2. PCB manufacturing investment of ₹1,500 crore expected to generate peak revenue of ₹2,500 crore
  3. Solar energy expansion through KSolare moving beyond rooftop installations

Market corrections reveal fundamental strengths that aren't immediately apparent during bull markets. Companies with sustainable competitive advantages, clear growth trajectories, and strong execution capabilities can maintain investor confidence even when broader sentiment turns negative. The resilience demonstrated by Laurus Labs, Jain Resource Recycling, and Syrma SGS Technology underscores how markets reward quality over mere valuation metrics during challenging periods.